Best Esophageal cancer oncologists in Italy: TOP 5 doctors

Prof. Filippini began his career in 1980 and has been teaching at the University of Chieti since the 1990s in the fields of General Surgery, Microsurgery, Reconstructive Surgery, Vascular Surgery, Orthopedics, and Gynecology. His primary focus is oncological surgery, particularly specializing in "The surgical treatment of locally advanced tumors and multi-organ resections." He has enriched his expertise by visiting prominent reference centers in the United States, including the Memorial Sloan Kettering Cancer Center in Manhattan, New York City. There, he delved into minimally invasive, laparoscopic, and microsurgical techniques under the guidance of esteemed mentors such as John Daly, Michele Gagner, and Murray Brennan. Additionally, in 2005, he further expanded his skills at the City of Hope Oncology Center in Los Angeles, focusing on robotic surgery in oncology.

In 1980, Prof. Filippini graduated in Medicine and Surgery from the G. D'Annunzio University of Chieti in Italy with honors, presenting an experimental thesis on lympho-venous anastomosis using microsurgical techniques. He completed his specialization in general surgery at the University of Pisa with distinction after five years. In 1990, he obtained another specialization in Plastic and Reconstructive Surgery from the University of Padua in Italy, where he maintained a stellar academic record.

Prof. Filippini has presented at numerous national and international conferences and authored over 100 scientific publications. Additionally, he has co-authored two monographs. 

Professor Riccardo Rosati is the Head of the Gastrointestinal Surgery (GI) Department at the San Raffaele Research Hospital in Milan, Italy. He is a highly experienced surgeon with over 30 years of experience, having completed medical degrees in general medicine and general surgery, as well as specialization in thoracic surgery. He is a member of multiple surgical associations, and has written over 300 publications. His department treats approximately 2,000 surgical cases per year.

Professor Michele Reni is an experienced medical oncologist with over 30 years of practice based in Italy. He specializes in pancreatic adenocarcinoma, gastro-esophageal cancers, and central nervous system tumors. He has published over 180 papers on cancer treatment and is the coordinator of Italian Association of Medical Oncology (AIOM) guidelines for treatment and management of pancreatic cancer. He has also chaired numerous clinical trials on treating patients with metastatic pancreatic cancer.

Member of SICOB - Italian Society of Obesity Surgery and ACOI - Association of Italian Hospital Surgeons                                               

Dr Braun is a board-certified general surgeon with over 25 years of experience specializing in gastrointestinal surgery, particularly in the treatment of gastroesophageal reflux disease (GERD) through Fundoplication surgery. He has performed over 500 successful Nissen and Toupet Fundoplication procedures, with a focus on minimally invasive laparoscopic techniques. His expertise extends to diagnosing complex cases of GERD and offering comprehensive treatment plans to improve patient outcomes.

He has carried out his main training experiences in various international institutions and specialization courses in general and digestive system surgery, including a two-year training internship at Johns Hopkins University, Division of Hepatobiliary Pancreatic Surgery and numerous courses in Madrid, with Prof. E. Moreno Gonzales (Curso Internacional de Actualizaciòn en chirurgia General y del Aparato Digestivo) or in New Orleans (Medical Education at the 90th Annual Clinical Congress of the American College of Surgeons).

Dr. Braun has extensive expertise in the field of digestive surgery. He has focused on implementing advanced protocols and optimizing surgical techniques, while maintaining high standards of safety and patient care. He has collaborated with a multidisciplinary team to provide an integrated and personalized approach in the management of obese or digestive disorder patients, improving quality of life and reducing post-operative complications.

Prof. Deraco has dedicated his career to helping patients with complex cancers, particularly those affecting the peritoneum, a membrane in the abdomen. He began his medical career in 1989 at the Surgery and Experimental Oncology Departments of the Fondazione IRCCS, National Cancer Institute in Milan, Italy. Over the years, he has played a key role in advancing treatments for peritoneal surface malignancies (PSM). For more than a decade, he was the lead physician for the Peritoneal Surface Malignancies Program. Since 2017, he has served as the director of the Peritoneal Surface Malignancies Unit, where he continues to focus on providing cutting-edge care for his patients.

Prof. Deraco’s expertise is in specialized cancer treatments like Cytoreductive Surgery (CRS), Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC), and Pressurized Intra-Peritoneal Aerosolized Chemotherapy (PIPAC). These techniques aim to remove cancer and deliver heated chemotherapy directly to the abdomen, giving patients with PSM new hope. He has successfully treated over 1,200 patients using these advanced methods.

In addition to his clinical work, Prof. Deraco is a professor at Milan University, where he teaches future surgeons about peritoneal surface malignancies. His teaching extends internationally, as he has mentored over 30 postdoctoral fellows from prestigious institutions worldwide.

Prof. Deraco’s educational background is extensive. He earned his medical degree from the University of Messina in 1987 with top honors, followed by a specialization in general surgery five years later. His training continued in Paris, where he specialized in oncology at the prestigious Paris Dauphine University. He further honed his skills through fellowships in world-renowned institutions such as the Gustave Roussy Institute in France, the Royal Marsden Hospital in the UK, and the Washington Cancer Institute in the USA.

Throughout his career, Prof. Deraco has remained actively involved in research and professional organizations. He has published over 250 scientific articles and 25 book chapters, contributing to the advancement of cancer treatment globally. He serves on the board of multiple scientific societies dedicated to cancer research, including the Peritoneal Surface Oncology International Group (PSOGI) and the Italian Society for Loco-Regional Cancer Therapy (SITILO).